GlassScriptPhysician profile
Rick E Peterson
NPI 1841381340
$6,850.67
in general payments reported to CMS, 2019-2025
15 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,924 · 2020: $212 · 2021: $725 · 2022: $1,060 · 2023: $1,233 · 2024: $451 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $482 · Entertainment: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $481.67 |
| Entertainment | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $3,703.89 | 2019-2025 | Myday Contact Lens, Paragon Crt, Biofinity Contact Lens |
| Alcon Vision LLC | $1,849.06 | 2019-2025 | Total30, Precision 1, Precision7 |
| Bausch & Lomb Americas INC. | $319.08 | 2022-2023 | Infuse, Biotrue One Day |
| Carl Zeiss Meditec, INC. | $150.00 | 2022 | |
| Sight Sciences, INC. | $142.19 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $129.85 | 2019-2023 | Spectacle Lenses, Contact Lens |
| Eyevance Pharmaceuticals LLC | $126.93 | 2021-2023 | Tobradex St |
| Carl Zeiss Meditec USA, INC. | $119.07 | 2021 | |
| Maculogix, INC. | $72.90 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $64.30 | 2019 | |
| Abbvie INC. | $62.83 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $47.01 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $28.56 | 2025 | Xdemvy |
| Lombart Brothers, INC. | $20.00 | 2019 | |
| Optos, INC. | $15.00 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.